Skip to main content
Log in

Intra-tracheal delivery of mesenchymal stem cell-conditioned medium ameliorates pathological changes by inhibiting apoptosis in asthmatic rats

  • Original Article
  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

Background

Asthma, an inflammatory illness of the lungs, remains the most common long-term disease amongst children. This study tried to elaborate the status of apoptosis in asthmatic pulmonary niche after the application of rat mesenchymal stem cells (MSC-CM)-derived secretome.

Methods and results

Here, we randomly allocated male Wistar rats into three groups (n = 8); Control animals were intratracheally given 50 μl vehicle. In control-matched sensitized rats, 50 μl normal saline was used. In the last group, 50 μl MSC-CM was applied. Two-week post-administration, transcription of T-bet, GATA-3, Bax, Bcl-2 and Caspase-3 was measured by gene expression analysis. Pathological injuries were monitored using H&E staining. The BALF level of TNF-α was measured using ELISA assay. In asthmatic rats received MSC-CM, the expression of T-bet was increased while the level of GATA-3 decreased compared to the S group (p < 0.05). Levels of BALF TNF-α were suppressed in asthmatic niche after MSC-CM administration (p < 0.05). Compared to the asthmatic group, MSC-CM had potential to alter the expression of apoptosis-related genes in which the expression of Bax and Caspase 3 was decreased and the expression of pro-survival factor, Bcl-2 increased (p < 0.05).

Conclusion

Our data notified the potency of direct administration of MSC-CM in the alleviation of airway inflammation, presumably by down regulating apoptotic death in pulmonary niche.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Ahmadi M, Rahbarghazi R, Shahbazfar A-A, Baghban H, Keyhanmanesh R (2018) Bone marrow mesenchymal stem cells modified pathological changes and immunological responses in ovalbumin-induced asthmatic rats possibly by the modulation of miRNA155 and miRNA133. Gen Physiol Biophys 37(3):263–274

    Article  CAS  PubMed  Google Scholar 

  2. Afzal S, Ramzan K, Waqar AB (2020) Alternative approaches for the treatment of asthma and COPD: focus on cell-based therapies, epigenetics, and gene silencing approaches. Adv Life Sci 7(3):181–189

    CAS  Google Scholar 

  3. Rahbarghazi R, Keyhanmanesh R, Aslani MR, Hassanpour M, Ahmadi M (2019) Bone marrow mesenchymal stem cells and condition media diminish inflammatory adhesion molecules of pulmonary endothelial cells in an ovalbumin-induced asthmatic rat model. Microvasc Res 121:63–70

    Article  CAS  PubMed  Google Scholar 

  4. Keyhanmanesh R, Rahbarghazi R, Aslani MR, Hassanpour M, Ahmadi M (2018) Systemic delivery of mesenchymal stem cells condition media in repeated doses acts as magic bullets in restoring IFN-γ/IL-4 balance in asthmatic rats. Life Sci 212:30–36

    Article  CAS  PubMed  Google Scholar 

  5. Mirershadi F, Ahmadi M, Rezabakhsh A, Rajabi H, Rahbarghazi R, Keyhanmanesh R (2020) Unraveling the therapeutic effects of mesenchymal stem cells in asthma. Stem Cell Res Ther 11(1):1–12

    Article  Google Scholar 

  6. Goldstein BD, Lauer ME, Caplan AI, Bonfield TL (2017) Chronic asthma and Mesenchymal stem cells: hyaluronan and airway remodeling. J Inflamm 14(1):18

    Article  Google Scholar 

  7. Dong F, Wang C, Duan J, Zhang W, Xiang D, Li M (2014) Puerarin attenuates ovalbumin-induced lung inflammation and hemostatic unbalance in rat asthma model. Evid-Based Complement Altern Med. https://doi.org/10.1155/2014/726740

    Article  Google Scholar 

  8. Tukmechi A, Rezaee J, Nejati V, Sheikhzadeh N (2014) Effect of acute and chronic toxicity of paraquat on immune system and growth performance in rainbow trout. O ncorhynchus mykiss Aquac Res 45(11):1737–1743

    CAS  Google Scholar 

  9. Salimi L, Akbari A, Jabbari N, Mojarad B, Vahhabi A, Szafert S et al (2020) Synergies in exosomes and autophagy pathways for cellular homeostasis and metastasis of tumor cells. Cell Biosci 10:1–18

    Article  Google Scholar 

  10. Cruz FF, Rocco PRM (2020) The potential of mesenchymal stem cell therapy for chronic lung disease. Expert Rev Respir Med 14(1):31–39

    Article  CAS  PubMed  Google Scholar 

  11. Caretti A, Peli V, Colombo M, Zulueta A (2020) Lights and shadows in the use of mesenchymal stem cells in lung inflammation, a poorly investigated topic in cystic fibrosis. Cells 9(1):20

    Article  CAS  Google Scholar 

  12. Ahmadi M, Rahbarghazi R, Shahbazfar A-A, Keyhanmanesh R (2018) Monitoring IL-13 expression in relation to miRNA-155 and miRNA-133 changes following intra-tracheal administration of mesenchymal stem cells and conditioned media in ovalbumin-sensitized rats. The Thai J Vet Med 48(3):347–355

    Google Scholar 

  13. Du YM, Zhuansun YX, Chen R, Lin L, Lin Y, Li JG (2018) Mesenchymal stem cell exosomes promote immunosuppression of regulatory T cells in asthma. Exp Cell Res 363(1):114–120. https://doi.org/10.1016/j.yexcr.2017.12.021

    Article  CAS  PubMed  Google Scholar 

  14. Jabbari N, Nawaz M, Rezaie J (2019) Bystander effects of ionizing radiation: conditioned media from X-ray irradiated MCF-7 cells increases the angiogenic ability of endothelial cells. Cell Commun Signal 17(1):1–12

    Article  Google Scholar 

  15. Ahmadi M, Rahbarghazi R, Aslani MR, Shahbazfar A-A, Kazemi M, Keyhanmanesh R (2017) Bone marrow mesenchymal stem cells and their conditioned media could potentially ameliorate ovalbumin-induced asthmatic changes. Biomed Pharmacother 85:28–40

    Article  CAS  PubMed  Google Scholar 

  16. Mohammadipoor A, Antebi B, Batchinsky AI, Cancio LC (2018) Therapeutic potential of products derived from mesenchymal stem/stromal cells in pulmonary disease. Respir Res 19(1):218

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Liu Y, Pu Y, Li D, Zhou L, Wan L (2017) Azithromycin ameliorates airway remodeling via inhibiting airway epithelium apoptosis. Life Sci 170:1–8

    Article  PubMed  Google Scholar 

  18. Nikfarjam S, Rezaie J, Kashanchi F, Jafari R (2020) Dexosomes as a cell-free vaccine for cancer immunotherapy. J Exp Clin Cancer Res 39(1):1–20

    Article  Google Scholar 

  19. Keyhanmanesh R, Rahbarghazi R, Ahmadi M (2018) Systemic transplantation of mesenchymal stem cells modulates endothelial cell adhesion molecules induced by ovalbumin in rat model of asthma. Inflammation 41(6):2236–2245

    Article  CAS  PubMed  Google Scholar 

  20. Ahmadi M, Rahbarghazi R, Soltani S, Aslani MR, Keyhanmanesh R (2016) Contributory anti-inflammatory effects of mesenchymal stem cells, not conditioned media, on ovalbumin-induced asthmatic changes in male rats. Inflammation 39(6):1960–1971

    Article  CAS  PubMed  Google Scholar 

  21. Oskuye ZZ, Bavil FM, Hamidian GR, Mehri K, Qadiri A, Ahmadi M et al (2019) Troxerutin affects the male fertility in prepubertal type 1 diabetic male rats. Iran J Basic Med Sci 22(2):197

    Google Scholar 

  22. Chien KR, Frisén J, Fritsche-Danielson R, Melton DA, Murry CE, Weissman IL (2019) Regenerating the field of cardiovascular cell therapy. Nat Biotechnol 37(3):232–237

    Article  CAS  PubMed  Google Scholar 

  23. Guo H-W, Yun C-X, Hou G-H, Du J, Huang X, Lu Y et al (2014) Mangiferin attenuates TH1/TH2 cytokine imbalance in an ovalbumin-induced asthmatic mouse model. PloS one. 9(6):e100394

    Article  PubMed  PubMed Central  Google Scholar 

  24. Yan J, Deng N, Wang Q, Du X, Li C, Xie T et al (2020) Xiaoqinglong decoction reduces dendritic cell differentiation and regulates the Th1/Th2 balance in a mouse model of allergic asthma. J Tradit Chin Med Sci 7(2):133–140

    Google Scholar 

  25. Lu N, Bai Y, Zhao C, Tian L, Wan X, Jin R (2020) Effect of Huai Qi Huang on asthma in rats and the mechanism research. Zhongguo Dang dai er ke za zhi = Chin J Contemp Pediatr 22(2):171–6

    Google Scholar 

  26. Ezz-Eldin YM, Aboseif AA, Khalaf MM (2020) Potential anti-inflammatory and immunomodulatory effects of carvacrol against ovalbumin-induced asthma in rats. Life Sci 242:117222

    Article  CAS  PubMed  Google Scholar 

  27. Hodge S, Hodge G, Jersmann H, Matthews G, Ahern J, Holmes M et al (2008) Azithromycin improves macrophage phagocytic function and expression of mannose receptor in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 178(2):139–148

    Article  CAS  PubMed  Google Scholar 

  28. Habibian R, Delirezh N, Farshid AA (2018) The effects of bone marrow-derived mesenchymal stem cells on ovalbumin-induced allergic asthma and cytokine responses in mice. Iran J Basic Med Sci 21(5):483–488. https://doi.org/10.22038/IJBMS.2018.26898.6575

    Article  PubMed  PubMed Central  Google Scholar 

  29. Li H, Tian Y, Xie L, Liu X, Huang Z, Su W (2020) Mesenchymal stem cells in allergic diseases: current status. Allergol Int 69(1):35–45. https://doi.org/10.1016/j.alit.2019.08.001

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

Authors wish to thank the personnel Drug Applied Research Center of Tabriz University of medical sciences for guidance and help.

Funding

The present study received a grant from Tabriz University of Medical Sciences (No: TBZMED. REC.1399.069).

Author information

Authors and Affiliations

Authors

Contributions

RK, FM and HH performed rat model of asthma and sampling, HSB, SS, AR and HR performed ELISA and real-time PCR analysis; RR, AD and YB did the pathological examination and IF imaging; MA supervised the study. All authors approved the manuscript. All authors have seen and approved the final version of the manuscript being submitted. We warrant that the article is the authors’ original work, and it hasn’t received prior publication and isn’t under consideration for publication elsewhere.

Corresponding author

Correspondence to Mahdi Ahmadi.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Ethical approval

The study received approval from Ethical Committee of Tabriz University of Medical Sciences (No: TBZMED. REC.1399.069). Animal care and handling procedures were conducted in accordance with the guideline for the Care and Use of Laboratory Animals (National Institutes of Health, publication no 85‐23, revised 1985).

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Keyhanmanesh, R., Khodamoradi, F., Rahbarghazi, R. et al. Intra-tracheal delivery of mesenchymal stem cell-conditioned medium ameliorates pathological changes by inhibiting apoptosis in asthmatic rats. Mol Biol Rep 49, 3721–3728 (2022). https://doi.org/10.1007/s11033-022-07212-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-022-07212-8

Keywords

Navigation